MedTrace Logo

Socket Preservation: A Clinical and Histological Study

NCT03422692 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2018-02-14

No results posted yet for this study

Summary

The objective of this study is to investigate the use of human amnion chorion membrane (BioXclude®) as an exposed barrier in ridge preservation and whether the intentional exposure of this membrane to oral environment will adversely affect ridge healing, dimensions, and bone vitality. This is a randomized clinical study.

Conditions

  • Alveolar Ridge Augmentations

Interventions

BIOLOGICAL

BioXclude amnion-chorion membrane

BioXclude will be used for the prevention of alveolar ridge resorption via socket bone graft and amnion-chorion membrane closure

BIOLOGICAL

Mem-Lok collagenous membrane

Mem-Lok will be used for the prevention of alveolar ridge resorption via socket bone graft and collagenous membrane closure

Sponsors & Collaborators

  • University of Kentucky

    lead OTHER

Principal Investigators

  • Mohanad Al-Sabbagh, DDS, MS · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2015-10-01
Completion
2015-10-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03422692 on ClinicalTrials.gov